1. Correctly match an identified diabetes complication with its type (e.g., microvascular or macrovascular):
A. Peripheral vascular disease – Microvascular complication
B. Neuropathy – Microvascular complication
C. Retinopathy – Macrovascular complication
D. Erectile dysfunction – Macrovascular complication
2. All of the following are examples of macrovascular complications of diabetes, EXCEPT:
A. Nonproliferative Diabetic Retinopathy (NPDR)
B. Peripheral Vascular Disease
C. Cardiovascular Disease
D. Myocardial Infarction
3. Which of the following is considered a concordant comorbidity with diabetes?
A. Stage IV breast cancer
B. Hypertension
C. Obstructive Sleep Apnea
D. Nonalcoholic Fatty Liver Disease
4. Which of the following is considered a clinically dominant comorbidity in a patient with diabetes?
A. Dyslipidemia
B. Hypertension
C. Severe depression
D. Irritable bowel syndrome
5. Which of the following medication classes is recommended as preferred for glucose-lowering in addition to metformin in patients with diabetes and chronic kidney disease (CKD) (provided they have sufficient kidney function to indicate use)?
A. Thiazolidinediones
B. SGLT2 inhibitors
C. DPP-4 inhibitors
D. Sulfonylureas
6. An inflammatory process occurs in diabetic neuropathy that can lead to nerve damage. Contributing factors to this inflammatory process include:
A. High blood glucose
B. Low body mass
C. Oxidative Stress
D. Both A and C
7. Which of the following therapies is U.S. Food and Drug Administration (FDA)-approved for the treatment of diabetic peripheral neuropathy:
A. Nortriptyline
B. Duloxetine
C. Amitriptyline
D. Capsaicin
8. A female patient who is 55 years old and has a history of a myocardial infarction (MI). She is not currently receiving aspirin therapy. Based on current guideline recommendations, which of the following is correct?
A. Aspirin therapy (75-162 mg/day) is recommended for secondary prevention
B. Aspirin is no longer used in the patient with diabetes
C. Recommend Aspirin 325mg twice daily
D. Aspirin is only recommended for primary prevention in people with diabetes
9. Which type of diet plan works best to help lower blood pressure in patients with diabetes?
A. Atkins Diet
B. DASH Diet
C. Gluten Free Diet
D. Vegan Diet
10. All of the following medications are recommended by the ADA as a first-line option for the treatment of painful diabetic peripheral neuropathy (DPN), EXCEPT:
A. Duloxetine
B. Pregabalin
C. Gabapentin
D. Amitriptyline
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Will the information presented cause you to change your practice?
A. Yes
B. No
23. Are you committed to making these changes?
A. Yes
B. No
24. As a result of this activity, did you learn something new?
A. Yes
B. No
25. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
26. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20